ImmunoGen IMGN
$ 31.23
0.0%
Quarterly report 2023-Q3
added 11-02-2023
Country |
USA |
IPO year |
1989 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Mark Enyedy |
Employees in the company |
75 |
Shares |
254 M |
Market Cap[1] |
$ 7.92 B |
EBITDA (LTM) |
$ -201 M |
P/E (LTM) |
-39.74 |
P/S (LTM) |
15.02 |
EPS (LTM) |
-0.39 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.